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 28 
ABSTRACT 29 
 30 
Measles virus (MeV) infection is characterized by the formation of multinuclear giant cells 31 
(MGC). We report that IFN-β production is amplified in vitro by the formation of virus-induced 32 
MGC derived from human epithelial cells or mature conventional dendritic cells (mDC). Both 33 
fusion and IFN-β response amplification was inhibited in a dose dependent way by a fusion 34 
inhibitory peptide after MeV infection of epithelial cells. This effect was observed at both low 35 
and high multiplicity of infection. While in the absence of virus replication, the cell-cell fusion 36 
mediated by MeV H/F glycoproteins did not activate any IFN-α/β production, an amplified IFN-37 
β response was observed by infecting H/F-induced MGC with a non fusogenic recombinant 38 
chimerical virus. Time-lapse microscopy studies revealed that MeV-infected MGC from 39 
epithelial cells have a highly dynamic behavior and an unexpected long lifespan. Following the 40 
cell-cell fusion, both of the RIG-I and IFN-β gene deficiencies were trans-complemented to 41 
induce an IFN-β production. IFN-β and IFN-α production were also observed in MeV-infected 42 
immature and mature DC (iDC and mDC). In contrast to iDC, MeV infection of mDC induced 43 
MGC which produced enhanced amounts of IFN-α/β. The amplification of IFN-β production 44 
was associated with a sustained nuclear localization of IFN regulatory factor 3 (IRF-3) in MeV-45 
induced MGC derived from both the epithelial cells and mDC, while the IRF-7 up-regulation was 46 
poorly sensitive to the fusion process. Therefore, MeV-induced cell-cell fusion amplifies IFN-47 
α/β production in infected cells and this indicates that MGC contribute to the antiviral immune 48 
response. 49 
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INTRODUCTION 50 
 51 
Measles virus (MeV) is an important human pathogen responsible for ~345 000 of deaths in 52 
2005 (http://www.who.int/mediacentre/factsheets/fs286/en/). However, most humans clear this 53 
viral infection provided that they have a functional cellular and adaptive immunity (19). MeV 54 
infection begins in the respiratory tract and then spreads to local lymphoid tissues, where virus 55 
replication can occur in macrophages and possibly conventional dendritic cells (cDC) (14, 17, 22, 56 
49, 70). This allows MeV spreading to other lymphoid organs and to the whole body. MeV 57 
induces a cytopathic effect characterized by the fusion of neighboring cells into multinucleated 58 
giant cells (MGC). In vivo, seven days after MeV infection of rhesus monkeys, MGC are found in 59 
respiratory and genitourinary tract, as well as in the esophagus and skin epithelia (47). In 60 
addition, a specific subset of infected MGC called Warthin-Finkeldey cells (WFC), initially 61 
described in infants dying of acute measles, is found in primary and secondary lymphoid organs 62 
(19). WFC are usually observed in germinal centers and interfollicular areas of secondary 63 
lymphoid organs and in the thymus. They are heterogeneous and display either B or T cells 64 
markers (54), although macrophage and DC markers have not yet been investigated. In vitro, 65 
MeV infection of human cells, including primary epithelial cells and cDC, induces the formation 66 
of MGC also referred to as syncytia (17, 78, 82). MeV-induced cell-cell fusion is governed by the 67 
interaction of the viral envelope H and F glycoproteins with the cellular receptors CD46 and 68 
CD150, which are expressed ubiquitously and solely on immune activated cells, respectively 69 
(19). 70 
The hallmark of the immune response to a viral infection is the rapid production of a range of 71 
cytokines, most prominently type I IFN (IFN-α/β). The IFN-α/β enable cells to be protected 72 
against viral infection via pleiotropic activities such as inhibition of protein synthesis and cell 73 
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proliferation, and enhancement of infected cell apoptosis (reviewed in (5, 21)). They also activate 74 
Natural Killer (NK) cells and cytotoxic T cells (CTL) that are capable of eliminating the viral 75 
pathogen by killing infected cells. The IFN-α/β can act directly on CTL or indirectly by inducing 76 
the maturation of cDC, which facilitates cross-presentation of viral antigens to CTL (42, 43). The 77 
single IFN-β gene and most of the IFN-α genes differ in their promoter region, the former is 78 
activated by IFN regulatory factor 3 and 7 (IRF-3/IRF-7) heterodimers (56), whereas only IRF-7 79 
homodimers (25) and/or IRF-7/IRF-8 heterodimers as recently reported in mouse DC (75), can 80 
activate the latter. The recognition of peculiar danger molecular motifs of viruses is mediated by 81 
host pattern recognition receptors (PRR) (36), which can recognize virus nucleic acids. Two 82 
groups of PRR are involved in IFN production in DC, the Toll-like receptors (TLR) and the RIG-83 
like receptors (RLR). To date, TLR are mainly responsible for IFN-α production by plasmacytoid 84 
DC (pDC) via TLR7 and TLR9 (1), which respond to viral nucleic acids within the endosomal 85 
compartment. Nucleic acid recognition results in the activation of the IFN-α genes through the 86 
phosphorylation and the nuclear translocation of IRF-7 (26, 37). Indeed, in comparison with other 87 
cells, pDC express high level of IRF-7 (8, 30) and this allows pDC to produce 100- to 1000-fold 88 
more IFN-β and IFN-α than other cell types (26). TLR are also involved in IFN production by 89 
cDC via TLR3 after phagocytosis of infected cells (64). However, the IFN response in cDC 90 
principally relies on RLR (RIG-I and MDA-5) (34, 35), which are cytosolic PRR expressed in 91 
almost all nucleated cells and dedicated to respond to viral nucleic acids produced during 92 
replication ((28, 60, 87). MDA-5 and RIG-I recognized dsRNA (20) and 5’-triphosphate ended 93 
RNA (28, 60, 62), respectively. Accordingly, they recognize different types of RNA viruses, 94 
MDA-5 being activated by Picornaviridae and RIG-I by Flaviviridae, Orthomyxoviridae and 95 
Mononegavirales (20, 35). MeV activates RIG-I which recognizes the 5’-triphosphate end of the 96 
small RNA leader transcript (62). The activation of RLR induces the interaction with an adaptor 97 
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protein called IPS-1 (also known as MAVS, VISA, CARDIF) that leads to NF-κB, IRF-3 and 98 
IRF-7 phosphorylation and their transient translocation into the nucleus, resulting in the early 99 
IFN-β gene induction (34, 57). In contrast to the short-living IRF-7, the more stable IRF-3 is 100 
highly expressed in all cells (25). IFN-β is then secreted and binds to the IFNAR to produce late 101 
IFN-β and all IFN-α subtypes. Indeed, early IFN-β induces the transcription of numerous genes 102 
known as IFN-stimulated genes (ISG) (25), including IRF-7. The activation of this supplemental 103 
source of IRF-7 allows the delayed production of a boost of both IFN-β and IFN-α, according to 104 
a robust positive feedback loop, which amplifies the antiviral response (25). The crucial role of 105 
the RLR in the IFN-α/β response and control of viral replication has been recently highlighted in 106 
IPS-1 (or MAVS) deficient mice, which show normal IFN-α secretion by pDC (41, 74). 107 
In the case of MeV, IFN-α/β production has been found after in vitro infection of various 108 
human cell types including epithelial (from various tissues), endothelial, glial and PBMC (52, 84, 109 
85). MeV propagates more efficiently in mature cDC (mDC) than in immature cDC (iDC) and 110 
induces higher level of MGC formation in mDC (17, 66). Given the ability of MeV to induce 111 
MGC formation in epithelium and secondary lymphoid organs, we aimed at investigating, both in 112 
human epithelial cells and cDC, the role of MeV-induced cell-cell fusion on the regulation of 113 
IFN-α/β production. 114 
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 115 
MATERIALS AND METHODS 116 
 117 
Reagents. Antibodies used were: mAbs clone 55 (anti-H), clone 25, and 120 (anti-N), G28.5 118 
(anti-CD40) and rabbit polyclonal anti-human IRF-3. The following reagents were used: Hoechst 119 
33342 (Sigma), fusion-inhibiting peptide FIP Z-D-Phe-L-Phe-Gly-OH (Neosystem), rhGM-CSF 120 
and rhIL-4 (generously provided by Schering-Plough), rhIFN-β (Calbiochem, San Diego, CA), 121 
Draq5 (Alexis Biolabs).  122 
 123 
Cells and phenotypic analysis. Human kidney epithelial 293T/17 cells (ATCC) expressing 124 
CD46 (293T/CD46+), HeLa cells, African green monkey Vero fibroblasts (ATCC), 125 
293T/CD150+ (77), Huh7.5 cells, a subline of Huh7 defective in RIG-I (73), and human cortical 126 
TEC (P1.4D6 clone) from postnatal thymus (16) were maintained in DMEM medium 127 
supplemented with 10 % FCS or as described in (16, 73). Monocyte-derived DC were generated 128 
in vitro from human blood (Etablissement de Transfusion Sanguine, Lyon, France) as previously 129 
described (17). After 6 days of culture in 200 ng/ml rhGM-CSF and 10 ng/ml rhIL-4, >95% of 130 
the cells were iDC. The mDC were derived by treating iDC for 48 h with 10 µg/ml of mAb anti-131 
CD40. The cDC phenotyping was determined as previously described (17, 82).  132 
 133 
MeV infection. MeV (Hallé strain) and recombinant chimerical MGV (72) were maintained 134 
in Vero cells. For MeV infection experiments, cells were seeded overnight at appropriate density 135 
in a 24-well plate according to the duration of the observation to avoid cell crowding. 293T and 136 
TEC were infected at MOI of 1, unless otherwise indicated, then treated or not with FIP. DC 137 
were infected at MOI of 0.1 with MeV as previously detailed (17, 83). As controls, all cells were 138 
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pulsed with a mock preparation corresponding to uninfected Vero cell supernatant. In some 139 
experiments, FIP (100 µg/ml) was added to the cDC cultures infected or not with MeV. 140 
 141 
Transient cell transfections. 4x105 293T/CD46+ cells were plated on 6-well plates (BD, 142 
Falcon). The day after, cells were transfected either with 1 µg pCXN2-F (expressing Edm-F) plus 143 
1 µg pCXN2-EdH (expressing the CD46-binding HEd) or 1 µg pCXN2-KAH (expressing the HKA 144 
from the wild type KA MeV isolate which does not bind to CD46) (79), or 2 µg of pBSK+ carrier 145 
plasmid (Stratagene). All transfections were performed using Lipofectamine (Invitrogen) or 146 
Dreamfect (OZ Biosciences) according to manufacturers’ instructions.  147 
 148 
Time-Lapse. 2x106 293T/CD46+ cells were plated on a 6-well plate and infected with MeV 149 
at MOI of 1 as described above. After 24 h of culture in the presence of 10 µg/ml FIP, FIP was 150 
removed and the plate was placed on a 37°C heated in 5% CO2 atmosphere (Carl Zeiss, Jena, 151 
Germany). Cells were imaged by Metamorph software v6 with a Coolsnap HQ monochrome 152 
camera associated to timelapse microscope (Axiovert 100 M) and a x10 (numerical aperture 0.25) 153 
Plan-Apochromat objective (Zeiss). Meta Imaging Series 4.5 (Universal Imaging, West Chester, 154 
PA) was used to make Quick-Time movies from image stacks from metamorph software. One 155 
picture was made every 10 min for 60 hours and every second of movie represent 235.4 min 156 
(3.92 h) of culture (see Fig. S5video.mov). Images extracted from stacks were processed with 157 
Adobe Photoshop 6.0 (Adobe Systems, San Jose, CA). 158 
 159 
Co-culture experiments. 8 x 104 Huh7.5 and Vero cells were plated in 24-well plates 160 
(Costar) and were infected, 24 h later, with MeV at MOI of 1. At 8 h.p.i., Vero cells were 161 
trypsinized and added to the Huh7.5 cell monolayers at a 1:1 ratio, in the presence or absence of 162 
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10 µg/ml of FIP. Cell-free supernatants were harvested at different times and frozen before 163 
analysis for IFN-α/β using a biological assay.  164 
 165 
IFN-α and IFN-β detection assay. IFN-α/β contents in supernatants were determined using 166 
a bioassay as detailed elsewhere (84). IFN-α and IFN-β were determined by ELISA using the 167 
IFN-alpha kit from Bender MedSystems (detection limit = 8 pg/ml), and the IFN-beta kit from 168 
PBL Laboratories (detection limit = 250 pg/ml), respectively. 169 
 170 
RNA extraction, cDNA RT, and real-time QPCR analysis. A detained procedure can be 171 
found for viral RNA quantification in (61). Primer sets for human IFN-β and IRF-7 mRNA 172 
quantitation were forward TGGGAGGATTCTGCATTACC, and reverse 173 
CAGCATCTGCTGGTTGAAGA primers, respectively. The primer sets were purchased from 174 
Search-LC (Heidelberg, Germany). Results were normalized according to the amounts of 18S 175 
rRNA, and expressed in mRNA copy number / 25 ng of total RNA. 176 
 177 
MTT colorimetric bioassay. 4x103 293T/CD46+ cells were plated in a 96-well plate 178 
(Costar). At 30 h after infection or transfection, cells were treated with 225 ng/well of 3-(4,5-179 
dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT, Sigma) to measure 180 
mitochondrial activity of metabolically active cells. 4 h latter, the supernatant was removed and 181 
the cells were lysed with 100 µl/well DMSO containing 0.04 N HCl. Absorbance was then 182 
measured at 490 and 650 nm (18). 183 
 184 
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Quantitative fusion assay. This assay is based on the conditional expression of β-185 
galactosidase (β-Gal) under the control of the T7 polymerase promoter and was performed as 186 
previously described (7).  187 
 188 
Subcellular localization of GFP-IRF-3 proteins. 5x104 293T/CD46+ cells, seeded in 24 189 
well plate were infected or not with MeV at MOI of 1 for 2 h then transfected by the GFP-IRF-3 190 
expression plasmid (46) using lipofectamine. 24 to 48 h latter, GFP-fluorescence in living cells 191 
was analyzed with a Leica DM IRB microscope at a magnification of x400. The percent of IRF-192 
3-labeled nuclear was calculated by counting, within a microscope field, the total number of 193 
nuclei (belonging to mononuclear cells or MGCs, labeled and unlabeled,) and the number of 194 
nuclei labeled with GFP-IRF-3. In each condition, >100 nuclei were counted. 195 
 196 
Stainings. For nuclear staining, cell monolayers were stained with Hoechst 33342 as detailed 197 
previously (82) and the stained nuclei were observed using a Leica DM IRB microscope.  198 
MeV H cell surface expression was detected using cl55 mAb plus goat anti-mouse IgG 199 
phycoerytrin-conjugated secondary antibody (GAM-PE), (Jackson ImmunoResearch 200 
Laboratories) as previously described (82). MeV N intracellular detection was performed using 201 
Cytofix/Cytoperm kit (Becton Dickinson, Parmingen) and 293T/CD46+ cells were labeled using 202 
biotinylated cl25 mAb plus streptavidin-PE (Caltag Laboratories) as previously described (82). 203 
After labelling, cells were analyzed using a FACScalibur flow cytometer (Becton Dickinson 204 
Cellquest software). Integrated fluorescence was measured, and data were collected from at least 205 
5,000 events. 206 
Triple stainings were performed to visualized GFP-IRF-3 (green), MeV N protein (red) and 207 
nuclei (blue) by confocal microscopy assays. 2.5 x 104 293T/CD46+ cells were seeded onto pre-208 
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coated poly-L-Lysine (Sigma, 10 µg/ml, overnight at 4°C) glass coverslips in a 24-well plates 209 
and incubated 20 min at 37°C. 12 h later, cells were infected with MeV at a MOI of 0.1, 1, 2 and 210 
4, followed by transfection of the GFP-IRF-3 expression plasmid as described above, and then 211 
cultured in the absence or the presence of FIP at 10µg/ml. 48 h later, cells were fixed in 2% 212 
paraformaldehyde/PBS for 20 min at room temperature, treated with 0.1% Glycine/PBS for 10 213 
min at room temperature, and permeabilized with 0.5% Triton X-100/PBS for 5 min at room 214 
temperature. After washes with PBS, the fixed cells were blocked in BSA, human and goat 215 
serums, Triton X-100/PBS overnight at +4°C. Cells were then incubated with cl120 anti-N mAb 216 
for 90 min at +4°C. Cells were washed 3 times for 5 min in PBS before incubation with a GAM-217 
Alexa 568 for 30 min at +4°C. After 3 washes in PBS, cells were mounted on glass slides with 218 
mounting medium (Dako) containing Draq5 as nuclear marker. Labeled cells were imaged with a 219 
confocal microscope (Zeiss LSM510, 1 µm) using a zoomed (x2) 63X (NA 1.4) PlanFluor 220 
objective. To prevent cross-contamination between fluorochromes, each channel was imaged 221 
sequentially using a multi-track recording module before merging. 222 
Double staining was performed to visualize endogenous IRF-3 (green) and nuclei (blue) by 223 
Axioplan2 Imaging microscopy assays. Briefly, 8x104 mDC were seeded onto pre-coated poly-L-224 
Lysine glass coverslips in a 24-well plates and incubated 20 min at 37°C. 24h later, cells were 225 
infected at a MOI of 0.1, and then cultured in the absence or the presence of FIP at 100µg/ml. At 226 
3 d.p.i., cells were then fixed as for triple staining. Then, the fixed cells were blocked in 227 
BSA/serums/Triton X-100/PBS for 1 h at +4°C and incubated with rabbit anti-IRF-3 serum for 1 228 
h at +4°C. Cells were washed 3 times for 5 min in PBS before incubation with a goat anti-rabbit 229 
IgG Alexa 488-conjugated secondary antibody (Molecular Probes) for 30 min at +4°C. After 3 230 
washes in PBS, cells were incubated with 1 µg/ml of Hoechst 33343 for 15 min at room 231 
temperature before mounted on glass slides with mounting medium (Dako). Labelled cells were 232 
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analyzed with an Axioplan2 Imaging microscope (Zeiss, 0.3 µm) and then imaged by metamorph 233 
software V6. Images extracted from Z stacks were processed with Adobe Photoshop 6.0 234 
software. 235 
 236 
RESULTS 237 
MeV-induced cell-cell fusion amplifies IFN-β activation in epithelial cells. While MeV 238 
induced a high number of syncytia containing numerous nuclei in cells expressing both MeV 239 
receptors (293T/CD46+CD150+), syncytia were smallest and less numerous in 293T/CD46+ cells 240 
expressing only CD46 (not shown). MeV infection of 293T/CD46+ cells led to the accumulation 241 
of F viral transcripts and to the induction of IFN-β gene expression (data not shown). The 242 
accumulation of viral F mRNA and the transcription of the IFN-β gene were both enhanced in 243 
293T/CD46+CD150+ cells, compared to 293T/CD46+ cells (data not shown). Thus, the level of 244 
IFN-β activation was correlated to the virus transcription and/or to the cytopathic effects. 245 
To decipher how each of these could influence the IFN response, we took advantage of the 246 
availability of a fusion inhibitory peptide (FIP). FIP efficiently blocks the MeV-induced syncytia 247 
formation without inhibiting the cell-to-cell virus spreading (19). Addition of FIP repressed both 248 
syncytium formation and IFN-α/β production in MeV-infected 293T/CD46+ culture, without 249 
affecting the proportion of cells expressing MeV-N protein (Fig. 1A, left histogram). Whereas the 250 
fusion was totally inhibited by FIP, the IFN-α/β production by day 3 (not shown) and 7 p.i. (Fig. 251 
1A, left histogram) was inhibited by ~85-96%. This residual IFN-α/β production was significant, 252 
since no IFN-β could be detected in uninfected cells (data not shown). However, 293T cells 253 
expressing only MeV-Ed-H and -F glycoproteins readily fused into MGC, but did not secrete any 254 
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detectable IFN-α/β (data not shown). This indicates that cell-cell fusion, per se, does not activate 255 
the IFN-α/β response. 256 
A recombinant chimerical virus, MGV, where H and F genes have been substituted by that of 257 
the VSV G glycoprotein (72), infected and propagated more slowly in 293T/CD46+ cells without 258 
inducing syncytium formation. Accordingly, it induced a low level of IFN-β production which 259 
was insensitive to FIP (Fig. 1A, right histogram), and equivalent to that observed in FIP-treated 260 
MeV-infected 293T/CD46+ cells. Thus, MGV only triggered a basal level of IFN-α/β response, 261 
in agreement with the observation of the low IFN-α/β inducing ability of a non-fusogenic MeV 262 
variant (48). To confirm the enhancing effect of cell-cell fusion on MeV-induced IFN-β response, 263 
we compared the effect of expressing in trans a fusing (HEdF) and a non fusing (HKAF) (79) 264 
glycoprotein combination on the IFN-β response induced by MGV infection. As expected, the 265 
expression of HKAF did affect neither virus nor IFN-β transcription (not shown). In contrast, 266 
when compared to HKAF, the expression of HEdF induced large syncytia into 293T/CD46+ cells, a 267 
minor increase of viral transcription and a significant increase in the IFN-β gene activation (Fig. 268 
1B). Furthermore, the enhancing effect on the IFN-β response was much more pronounced in 269 
conditions ensuring that every single got infected, i.e. at MOI of 4, with a ~25 fold enhancement 270 
of IFN-β mRNA accumulation, compared to a limited 2.5 fold increase in virus transcript 271 
accumulation. 272 
When 293T/CD46+ cells were infected with fusogenic MeV at MOI ranging from 0.01 up to 273 
4 and analyzed at 30 h.p.i., the viral transcription of the F messenger exhibited a dose-response 274 
curve between MOI of 0.01 and 1 then reached a plateau (Fig. 1C, upper histograms). The 275 
identical level of viral transcription between MOI of 1 and 4 suggested that some viral 276 
interference occurred. In addition, at MOI higher than 1, a cytotoxicity, increasing with the MOI 277 
used, was observed, that likely resulted in part from cell fusion from without (i.e. fusion between 278 
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adjacent cells bridged by viral particles) (6), a reminder of viral induced hemolysis of CD46 279 
expressing Vervet monkey red blood cells (59). Furthermore, syncytia formation was much 280 
reduced when compared to lower MOI likely because of the strong down-regulation of CD46 281 
upon contact with the large amount of the hemagglutinin brought about by the high viral 282 
inoculum (39, 51). The level of IFN-β transcription followed the same dose-response between 283 
MOI of 0.01 and 1, to reach a plateau at MOI of 1, 2 and 4 (Fig. 1C, middle histograms). This 284 
correlation between viral transcription and IFN-β gene activation agrees with their parallel 285 
kinetics observed at MOI of 1 (62). Surprisingly, the production of IFN-α/β in the supernatant 286 
measured at 3 d.p.i. was almost identical between MOI of 0.1 and 4 (Fig. 1C, lower histograms). 287 
At MOI of 0.01, a small amount of IFN-α/β was detected only later at 7 d.p.i. (data not shown). 288 
The addition of FIP, which inhibited the formation of syncytia at all MOI (Fig. 1C), had minimal 289 
effects on viral transcription, but strongly inhibited IFN-β gene transcription and protein 290 
secretion (Fig. 1C, black columns), except at MOI of 4. Interestingly, in the presence of FIP, the 291 
amount of IFN released in the supernatant and the MOI correlated for MOI between 0.1 and 2 292 
(Fig. 1C and data not shown). At MOI of 0.01, the level of IFN released detected at 7 d.p.i. was 293 
also inhibited by FIP (not shown). The lack of FIP inhibitory effect at MOI of 4 was likely 294 
reflecting the side effects of the too high viral load mentioned above. 295 
Furthermore, after infection at MOI of 1, FIP inhibition of the cell-cell fusion observed at 30 296 
h.p.i. and 3 d.p.i., was dose-dependent as assessed by nucleus staining with Hoechst 33342 (Fig. 297 
2A, and data not shown), and the quantification assay using β-Gal as a reporter gene for 298 
intercellular fusion (Fig. 2B). A similar inhibition curve was also observed for the IFN-β mRNA 299 
(Fig. 2C and not shown). Strikingly, the best mathematical equation describing these two dose-300 
dependent responses had similar slopes (-11) and ordinates at the origin (+42 and +39).  301 
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In summary, MeV replication triggers a basal IFN-β response independently of H/F proteins 302 
and MeV-induced cell-cell fusion robustly amplifies this response in a dose-dependent manner at 303 
both low and high MOI. 304 
 305 
High morphologic plasticity of MeV-induced MGC. Viral induced fusion is usually 306 
correlated with apoptosis (13). As we observed an increased synthesis of IFN-β in MGC, we 307 
further analyzed the morphological plasticity of these cells. Thirty hours p.i., syncytia were found 308 
to be metabolically active, and able to convert MTT into intracellular formazan crystals, a 309 
hallmark of mitochondrial activity in viable epithelial cells (data not shown).  310 
Studies by time-lapse microscopy over 60 hours of MeV-infected 293T/CD46+ cells, showed 311 
the syncytia to be dynamic, exhibiting a morphology which varied with time (Fig. 3A, B and Fig. 312 
S3Avideo.mov). In the 1st stage, the initial flat adherent syncytium increased in size and nucleus 313 
contents (Fig. 3A, Adherent). Dynamic pseudopodia emerged from the syncytium to contact 314 
surrounding cells or syncytia. In a 2nd stage, the adherent syncytium retracted into highly 315 
refringent smooth balls (3rd stage), where nuclei were no longer visible, except upon examination 316 
under confocal microscopy of z-stacks after Hoechst staining (see below). Balls were highly 317 
mobile and rolled around. When they encountered surrounding healthy adherent mononuclear 318 
cells, they spread out into a secondary flat adherent syncytium with visible nuclei (4th stage). 319 
Then, the secondary adherent syncytium retracted again (5th stage), into an irregular ball with 320 
protruding blisters giving them a cauliflower appearance (6th stage), which rolled around. The 321 
duration of each stage was highly variable (see mean values on Fig. 3B), and most of the initial 322 
syncytia passed through stages 1, 2 and 3, half of them passed through stages 4 and 5 to reach 323 
stage 6, and another half directly passed from stage 3 to stage 6 (Fig. 3B). Of 17 initial syncytia 324 
recorded during 3 different experiments, none appeared to die before 60 hours. Furthermore, 325 
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when individual smooth or blistered balls were transferred onto a fresh uninfected 293T/CD46+ 326 
monolayer, they re-adhered. This suggests that syncytia may have an indefinite lifespan provided 327 
that they find within their vicinity a healthy cell monolayer (Fig. 3B, and data not shown). In 328 
contrast, when transferred to a plastic dish covered or not by collagen, both smooth and blistered 329 
balls became senescent and finally died to become floating and optically clear bubble-like 330 
structures (data not shown). Thus, MeV-induced syncytia are not prone to quickly die; instead, 331 
they may remain a viable entity. As controls, cell-to-cell fusion was observed neither in 332 
uninfected nor in FIP-treated MeV-infected 293T/CD46+ cells, indicating that none of the 333 
observed syncytium was due to merging senescent 293T/CD46+ cells (Fig. 3C and data not 334 
shown). 335 
 336 
Cell-cell fusion brings together both danger activation signal and IFN-β gene to trigger 337 
IFN-β induction. We then studied whether MeV-induced fusion can trigger trans-338 
complementation using Huh7.5 cells and Vero cells which have disabled RIG-I (73) and lack the 339 
IFN-β gene (11, 12), respectively. IFN-α/β was secreted and accumulated over time from both of 340 
the MeV-Huh7.5/Vero and MeV-Vero/Huh7.5 cell co-culture combinations, as syncytia were 341 
observed (Fig. 4). Moreover, the addition of FIP completely blocked both of the cellular fusion 342 
and the IFN-α/β production to undetectable levels. As expected, MeV infection of isolated 343 
Huh7.5 or Vero cells induced syncytia but did not trigger any IFN-α/β response. Thus, the RIG-I 344 
defect in human Huh7.5 cells and IFN-β gene defect in the simian Vero cells could be trans-345 
complemented in fused cells allowing the triggering of the human IFN-β gene. 346 
 347 
IRF-7 expression level is not influenced by MeV-induced fusion in epithelial cells. We 348 
then investigated whether the enhancement of IFN-β gene expression mediated by MeV-induced 349 
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cell-cell fusion correlate with the up-regulation of IRF-7. To this end, the level of IRF-7 350 
transcripts was analyzed in 293T/CD46+ cells and in the primary thymic epithelial cells (TEC), 351 
which are IFNAR-competent, in the presence or the absence of FIP (Fig. 5). In both of these cell 352 
types, MeV infection resulted in the activation of the IFN-β and IRF-7 genes. However, the level 353 
of IRF-7 transcripts remained unchanged when syncytia formation was blocked by FIP treatment, 354 
and did not correlate with the IFN-β mRNA level. Thus, the amplification of IFN-β activation by 355 
MeV-induced cell-cell fusion is not directly or solely controlled by the level of IRF-7 expression. 356 
 357 
MeV-induced cell-cell fusion amplifies IFN-α and IFN-β responses in human mDC, but 358 
not iDC. The phenomenon of the amplification of the IFN-α/β response by MeV-induced cell-359 
cell fusion was then examined in human monocyte-derived DC. More than 95% of iDC and mDC 360 
were CD1a+ and CD14- (data not shown). While the immature phenotype was confirmed by the 361 
low or negative expression of MHC class II, CD83, CD40, CD80 and CD86, mDC expressed 362 
high level of these molecules (data not shown). In agreement with previous reports (17, 50), both 363 
iDC and mDC, which have a CD46+CD150Low and CD46+CD150High phenotype, respectively 364 
(Fig. 6A) (50), were sensitive to MeV infection as shown by MeV-F transcription (Fig. 6B). 365 
However, the sensitivity to infection differed between iDC and mDC. MeV replication was faster 366 
in mDC in comparison with iDC with ~230-fold higher transcription at 3 d.p.i. (Fig. 6B). While 367 
the iDC only poorly fused, the MeV-infected mDC contained numerous giant MGC (Fig. 6), 368 
which expressed both viral proteins and mDC markers ((17), and data not shown). The addition 369 
of FIP to the cDC did not significantly affect the MeV-F transcription in the iDC and only 370 
partially reduced the MeV-F transcription in the mDC (Fig. 6B), while FIP efficiently inhibited 371 
the formation of MGC (Fig. 6). We then investigated the IFN-α/β production in cDC following 372 
MeV infection. MeV-infected iDC secreted significant levels of bioactive IFN-α/β (Fig. 6C) and 373 
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IFN-α (Fig. 6D). No IFN-β production was detected (Fig. 6E), even though IFN-β transcripts 374 
were observed (Fig. 6F), because of either the limited sensitivity of the ELISA, or the 375 
consumption of IFN-β by MeV-infected iDC (25). According to the very low level of cell-cell 376 
fusion observed within MeV infected iDC, the addition of FIP did not affect the IFN-α/β 377 
production (Fig. 6C and D). The MeV infected mDC produced significant levels of bioactive 378 
IFN-α/β, IFN-α, and IFN-β (Fig. 6C-E) and IFN-β mRNA (Fig. 6F). Both the MGC formation 379 
and IFN-α/β production by MeV-infected mDC was strongly inhibited in the presence of FIP 380 
(Fig. 6C-F). Thus, the MeV infection induces IFN-α/β responses in both of the iDC and mDC. 381 
However, the virus-induced cell-cell fusion amplifies both the IFN-α and IFN-β production only 382 
in mDC. Interestingly, MeV infection induced an IRF-7 up-regulation in the iDC, but not in mDC 383 
(Fig. 6G). Furthermore, FIP did not significantly affect the expression of IRF-7 in both DC types 384 
(Fig. 6G).  385 
As a control, the non fusiogenic chimerical virus MGV was also used to infect iDC and 386 
mDC. MGV only induced, in both iDC and mDC, a basal IFN response, which was not sensitive 387 
to FIP (data not shown). We noticed that, contrary to MeV, MGV replicated better in iDC than in 388 
mDC (Fig. 6A) and, accordingly, induced a stronger IFN-β gene transcription in iDCs. We 389 
speculate that the stronger endocytosis ability of iDC over mDC can favor MGV entry, which 390 
relies on the acidic endosomal pathway mediated by the VSV-G glycoprotein.  391 
Thus, MeV infection induces IFN-α/β responses in both iDC and mDC. However, the virus-392 
induced cell-cell fusion amplifies both IFN-α and IFN-β production only in mDC. 393 
 394 
Sustained nuclear translocation of IRF-3 in MeV-induced MGC derived from epithelial 395 
cells and mDC. MeV infection induces transactivation of the IFN-β gene through the 396 
phosphorylation and nuclear translocation of IRF-3 (65). Therefore, we analyzed the changes in 397 
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the subcellular IRF-3 localization using a GFP-tagged IRF-3 (GFP-IRF-3) transfected into 398 
293T/CD46+ cells. As expected (46), the GFP-IRF-3 was localized exclusively within the 399 
cytoplasm of uninfected cells (Fig. 7A, mock). After MeV infection, nuclei from a single 400 
syncytium exhibited a diverse level of GFP-IRF-3 staining, thus looking asynchronous, and a 401 
large proportion of syncytia contained nuclear IRF-3 whichever their stage. In addition, few 402 
mononuclear MeV-infected cells surrounding outside MGCs displayed nuclear localization of 403 
GFP-IRF-3 (not shown). In the absence of FIP, 50±24% of the nuclei belonging to MGC were 404 
labeled with GFP-IRF-3, whereas, only 6±7% of the small amount of single cells, which 405 
remained outside MGC, had their nuclei labelled (Fig. 7A, MeV). In the presence of FIP, 406 
although most cells were infected (see Fig. 1A, 7B and S7B), nuclear translocation of GFP-IRF-3 407 
was observed only in 4±2% of them (Fig. 7A, MeV+FIP, 2α=0.01 when compared to 50±24 % of 408 
nucleus labelling in the absence of FIP. In all cases, the nuclei were intact, including those in 409 
syncytia, as shown by Hoescht staining (Fig. 7A).  410 
Confocal analysis of GFP-IRF3 distribution in 293T/CD46+ cells infected with MeV at MOI 411 
of a 1 and 2 confirmed the high rate of nuclear IRF-3 labeling in MGC compared to mononuclear 412 
cells, and the presence of cytoplasmic N protein in all but rare cells, (data not shown). At the 413 
lower MOI of 0.1, similar results were obtained. Upon confocal analysis, many nuclei within 414 
MGC were labeled with GFP-IRF-3, whereas GFP-IRF-3 remained excluded from the nuclei of 415 
non infected cells (Fig. 7B, and data not shown). When the fusion was prevented by the addition 416 
of FIP, only few mononuclear cell nuclei displayed GFP-IRF3 labelling, although most of them 417 
were clearly infected as shown by cytoplasmic N labeling (Fig. 7B red dots and patches, and data 418 
not shown). Again, GFP-IRF-3 was translocated into the nuclei of MGC at all stages of the 419 
adherent-ball cycle described in Fig. 3 (Fig. 7B and data not shown). Interestingly, the 420 
distribution of both N and GFP-IRF-3 tended to change with the morphological stage of the 421 
MGC. When the syncytium was flat and adherent, GFP-IRF-3 showed dotted and/or reticulated 422 
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distribution in the nuclei and N protein had a dotted cytoplasmic distribution. When the 423 
syncytium underwent retractation into a smooth ball, the intensity of the nuclear GFP-IRF-3 424 
labeling became stronger and more diffuse and N protein tend to aggregate further into larger 425 
patches at the periphery of the cytoplasm (Fig. 7B, and data not shown). Thus, the amplification 426 
of IFN-β production induced by MeV-mediated fusion correlates with a sustained and strong 427 
nuclear translocation of IRF-3 within MGC at all their morphological stages. 428 
Localization of endogenous IRF-3 during infection of mDC was also studied. As expected, 429 
endogenous IRF-3 distributed exclusively within the cytoplasm of uninfected mDC (Fig. 7C, 430 
mock, left panels). At 3 d.p.i., IRF-3 (green) staining of many intact nuclei (blue stain) in 431 
syncytia MeV-infected mDC was observed (Fig. 7C, right panels, and supplemental material Fig. 432 
S7Cvideo.mov). Interestingly, the distribution of endogenous IRF-3 in the nuclei of mDC-433 
derived syncytia looked very similar to that of GFP-IRF-3 in nuclei of 293T-derived syncytia 434 
(compare Fig. 7C with 7A, B and data not shown). Addition of FIP strongly inhibited both MeV-435 
infected MGC from mDC and nuclear localization of endogenous IRF-3 (Fig. 7C, middle panel). 436 
Thus, endogenous IRF-3 tended to remain translocated into nuclei within MGC from MeV-437 
infected mDC in agreement with the sustained nuclear translocation of exogenous GFP-IRF-3 438 
within MGC derived from epithelial cells. 439 
 440 
DISCUSSION 441 
 442 
We report here that MeV-induced MGC or syncytia derived from epithelial cells and 443 
mDCs are metabolically active, long living and display both sustained nuclear translocation of 444 
IRF-3 and enhanced activation of the IFN-β gene. (i) There is a correlation between the fusogenic 445 
activity of MeV strain and IFN-β production. (ii) The fusion enhancing effect is observed at both 446 
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low and high MOI. (iii) The fusion inhibitory peptide FIP inhibits, in a dose dependent manner, 447 
both cell-cell fusion and IFN-β production. (iv) Cell-cell fusion mediated by MeV-H and -F 448 
glycoproteins does not activate any IFN-β response in the absence of viral infection, but does it 449 
after infection with MGV, a non-fusiogenic chimerical virus. (v) The cytosolic PRR RIG-I and 450 
the IFN-β gene are trans-complemented during the fusion process. (vi) Although both iDC and 451 
mDC are infected by MeV, only mDC undergo massive cell-cell fusion. In the mDC, a robust 452 
IFN-α/β production is mediated by MeV-induced cell-cell fusion (vii) In both epithelial cells and 453 
mDC, the fusion enhancing effect on IFN-β response appears to be mediated by a sustained 454 
nuclear IRF-3 localization, but does not directly correlate with the up-regulation of IRF-7 455 
expression. (viii) In response to MeV, iDC also produces an IFN-α/β production, but it is 456 
independent of the fusion process and likely amplified via IRF-7. Altogether, our results indicate 457 
that the MeV-induced MGC in epithelial cells and mDC are important sources of IFN-α/β and 458 
that the fusion can mediate an enhancement of IFN-α/β production without modulating the 459 
expression of IRF-7. 460 
Cell-cell fusion is a hallmark of many viral infections, and resulting MGC were thought to 461 
be short lived. Indeed, syncytia induced by the HIV-1 glycoprotein died by apoptosis by at least 462 
three different mechanisms: transient lipid exchange, activation of several kinases and 463 
transcription factors and contagious apoptosis (58). Surprisingly, MeV-induced MGC from 464 
epithelial cells were found to be viable and dynamic entities, capable of transducing intracellular 465 
signals throughout their morphological stage changes. Thus, from our in vitro observations, we 466 
can predict that the physiopathological MGC (WFC) observed in lymph nodes and thymus from 467 
MeV-infected children and primates should have a rather long lifespan in vivo (54, 76). However, 468 
as described by us and others (13, 58, 63, 82), syncytium apoptosis finally occurs, probably 469 
depending on cellular environment deprivation.  470 
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In non-pathological situations, the contents of a cell nucleus should be tightly regulated to 471 
ensure that every cell harbors a single nucleus. Notable exceptions are the fusion of cellular 472 
precursors undergoing a specific maturation process, such as the myotubes, the osteoclasts, and 473 
the syncytiotrophoblasts. In the two latter cases, a survival program is turned on (15, 31). 474 
Whether such a mechanism occurs for the survival of MeV-induced MGC remains to be 475 
determined. Strikingly, both of the MeV-induced MGC and syncytiotrophoblasts need to recruit 476 
fresh mononuclear cells in order to survive (29). Furthermore, given that IFN-β is used as a retro-477 
control feedback to limit the size of the osteoclasts by preventing further recruitment of new 478 
mononuclear cells (9), it could also regulate the dynamics of MGC formation induced by MeV as 479 
observed for other viruses (53, 80, 81, 86). 480 
The MeV induced cell-cell fusion results in MGC harboring an important function in the 481 
innate immunity, and it could be questioned if the fusion per se acts as an activation signal. 482 
Indeed, the artificial fusion of a human cell line with chicken erythrocytes results in the activation 483 
of both human and chicken IFN-β (23), the latter being indicative of a reactivation of the dormant 484 
chicken erythrocyte nucleus. The MeV induced cell-cell fusion is mediated by the H binding to 485 
the CD46 or CD150 cellular receptor which results in the activation of the fusion F protein (19). 486 
The H binding to CD46 has been reported to activate the IFN-β response and NO• production in 487 
murine macrophages expressing human CD46 (33). In human epithelial cells, the H/F and CD46-488 
mediated fusion per se was unable to trigger the IFN-β response, which required virus 489 
transcription (62). Likewise, we can exclude that the interaction of H with TLR2 is involved in 490 
the IFN-β activation since (i) the signaling downstream to TLR2 occurred independently of the F 491 
glycoprotein, (ii) the use of a wild type MeV with H protein unable to bind to CD46 and TLR2 492 
(4) gave similar results (not shown), and (iii) the TLR2 signaling pathway is not linked to IFN-493 
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α/β production. Altogether, MeV-induced cell-cell fusion in human epithelial cells is not directly 494 
sensed as a danger signal by the innate cellular machinery.  495 
MeV infection of human epithelial cells triggers the production of IFN-β, which is 496 
differentially regulated in mononuclear cells and MGC. At the beginning of the viral infection, 497 
the activation of IFN-β occurs in MeV-infected mononuclear cells where the cytosolic RIG-I is 498 
activated upon recognition of the 5’-tri-phosphate end of MeV leader RNA (62), and this results 499 
in the activation of IRF-3. Then, IRF-3 undergoes phosphorylation, homo- or hetero-500 
dimerization, nuclear translocation, fixation on IFN sensitive responsive elements (ISRE) and 501 
degradation by the ubiquitin-proteasome pathway (3, 65). In a later phase, the amplification of 502 
IFN-β production in MeV-infected mononuclear epithelial cells can be mediated by the classical 503 
IFNAR/IRF-7-dependent positive feedback, as described for other viruses (27), since IRF-7 is 504 
up-regulated after MeV infection. In contrast, the robust IFN-β production mediated by MGC 505 
from epithelial cells could not be explained solely by the IRF-7 up-regulation, because the latter 506 
was poorly sensitive to the fusion process. As described for an infection with respiratory 507 
syncytial virus, IRF-3 nuclear translocation occurs early within few hours after infection, then it 508 
drops rapidly within 15 hours because of the anti-interferon activity of non structural proteins 509 
(71). Therefore, the presence of a high IRF-3 nuclear translocation within MGC at a late time (30 510 
h.p.i.) of the MeV infection is unexpected and supports an essential role of IRF-3 in the MGC-511 
mediated amplification of the IFN-β production. It is possible that MeV proteins with IFN 512 
antagonist activity are diluted out upon fusion of MGC with uninfected cells, thus allowing a 513 
stronger and more sustained IFN production. It remains to be determined if the sustained IRF-3 514 
nuclear localization within MGC occurs as phosphorylated IRF-3 homodimers or IRF-3/IRF-7 515 
heterodimers.  516 
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What could be the mechanism, which enables cell fusion to boost the IFN-β activation ? 517 
At low MOI (virus to cell ratio <1) of infection, we propose the following model. Since the RIG-I 518 
and IFN-β gene locus are trans-complemented during the cell-cell fusion, syncytia formation can 519 
boost IFN-β transcription by bringing uninfected cells into contact with viral PAMPs. At a given 520 
time, the level of IFN-β activation results from the balance between available trigger viral RNA 521 
(PAMPs), RIG-I (PRR), pathway components (i.e. IRF-3) and viral IFN antagonists. The 522 
sustained nuclear localization of IRF-3 in the nuclei within syncytia at low MOI is compatible 523 
with the continuous recruitment of non infected cells which can result either in a weaken 524 
concentration of viral antagonists, and/or the recruitment of “naive” RIG-I/pathway components 525 
molecules by MeV leader RNA which would be produced in excess over the amount of RIG-526 
I/pathway components available in a single cell. At high MOI, an alternative model should be 527 
made since all individual cells get infected prior to the fusion event and the fusion-mediated 528 
amplification of the IFN-β response is even higher (see Fig. 1B). The IRF-3 nuclear translocation 529 
could be sustained within MeV-induced MGC, because of a synergistic activity such as 530 
stabilization of phosphorylated IRF-3 by activation of the DNA-dependent protein kinase (DNA-531 
PK) (32). This will require further investigations. Presently, our data thus argue for two non 532 
exclusive mechanisms involved in the fusion enhancing effect on IFN-β activation, one, 533 
evidenced at low MOI, is the recruitment of non infected cells to MeV-infected MGC, and the 534 
other, at high MOI, is a synergistic effect of cell fusion and virus infection. In both cases, there is 535 
a sustained nuclear translocation of IRF-3 within MGC, the underlying mechanism of which 536 
remains to be more deeply examined. In every case, the amplification of IFN-β response by MGC 537 
derived from MeV-infected epithelial cells upgrades the alert level of the innate immune response 538 
against viral infection in peripheral tissues. 539 
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During natural infection, MeV infects lung epithelial cells and/or resident iDC in epithelia 540 
and mucosa, and likely induces local IFN-α/β production, which could limit MeV replication 541 
(45). Then, infected iDC can migrate and disseminate the virus to the draining lymph nodes. 542 
There, they can be stimulated via CD40L by encountering naive T lymphocytes and become 543 
activated and more permissive to MeV replication as shown experimentally (66). Because the 544 
mDC are prone to fuse with surrounding cells, they form MGC, which could correspond to the 545 
WFC found in lymphoid organs. This results in a high virus progeny, which can propagate 546 
throughout the body. There are several examples of IFN-α/β production by human or mouse iDC 547 
(2, 34, 35) infected in vitro by few viruses, including MeV (38). Here, we demonstrate that upon 548 
MeV infection, both of the iDC and mDC produce IFN-β and IFN-α in vitro. The iDC display 549 
low permissiveness to MeV infection, and rapidly produce high levels of IFN-α and IFN-β 550 
independently of cell-cell fusion, probably through IFNAR/IRF-7 signaling as judged by the up-551 
regulation of IRF-7 expression. Since, IFN-α/β is quickly produced and secreted by iDC after 552 
infection with MeV (not shown), IFN-α/β can protect cells against the propagation of MeV and 553 
strongly limit the formation of MGC. As iDC are present in peripheral tissues and secrete IFN-554 
α/β, they can contribute to the establishment of the innate antiviral state by enhancing 555 
cytotoxicity of NK cells and activating macrophages (10, 40). In addition, the iDC constitute a 556 
critical link between innate and adaptive immunity (44, 67). Indeed, the IFN-α/β induce the up-557 
regulation of co-stimulatory molecules CD80, CD86 and CD40 on cDC (24), and the expression 558 
of TRAIL on iDC, which become cytotoxic (83). Thus, the IFN-α/β produced by MeV-infected 559 
iDC is a signal which upgrades the alarm level of the cellular innate immunity for detecting the 560 
invasion of a possible pathogen.  561 
In contrast to the iDC, the mDC are highly susceptible to MeV infection, form large MGC 562 
and produce high levels of IFN-α/β. The IFN-α/β is therefore less efficient in limiting MeV 563 
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growth and MGC formation within the mDC than within the iDC. The opposite phenotypes of 564 
iDC and mDC could originate from different relative kinetics of the infection and the innate 565 
antiviral response. Indeed, when the strength of the initial activation of IFN-β is too low 566 
compared to the virus growth kinetics, the rapid accumulation of MeV encoded anti-IFN V and 567 
possibly C proteins can block the intracellular IFNAR signaling pathway (55, 69), and this paves 568 
the way for unlimited virus growth. We therefore favor that the MGC can be promoted or 569 
repressed according to the respective speed and strength of virus growth and IFN-α/β production. 570 
Upon infection, the mDC produce IFN-α/β mostly from MGC, without any IRF-7 up-regulation. 571 
This suggests that the IFNAR/IRF-7 feedback loop is not directly involved. This data is in 572 
agreement with the down-regulation of IFNAR in cDC upon their maturation (68). As for 573 
epithelial cells, the robust production of IFN-α/β by the MeV-mediated MGC from mDC also 574 
correlated with a sustained activation of IRF-3. However, the induction of IFN-α independently 575 
of IRF-7 up-regulation in the MGC is questionable and the mechanism remains to be determined. 576 
The IFN-α/β produced by MGC from MeV-infected mDC could rather be involved in the 577 
establishment of MeV-specific adaptive immune response in the secondary lymph nodes. By 578 
providing high viral antigen load and IFN-α/β-dependent enhancement of the cross-priming to T 579 
cells (43), the paradoxical accumulation of virus and IFN-α/β within the MeV-mediated MGC 580 
probably contributes to the stimulation of the MeV-specific adaptive immune response, which 581 
will finally clear the virus from the organism. Finally, because of the different abilities of various 582 
laboratory, vaccine and wild type MeV to counteract the cellular innate immunity, the virus strain 583 
dependency of cell fusion-mediated amplification of the IFN-α/β response is also currently under 584 
investigation. 585 
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FIGURE LEGENDS 602 
 603 
Figure 1. Role of cell-cell fusion and MeV infection in the IFN-β response. (A) Syncytia 604 
formation scored as in Fig. S1, % of cells expressing MeV-N protein determined by flow 605 
cytometry, and IFN-α/β production at 7 d.p.i. after infection of 293T/CD46+ cells with MeV (left 606 
histogram), or recombinant chimerical MGV (right histogram), in the absence (dotted columns) 607 
or presence of 10 µg/ml of FIP (black columns). (B) Syncytia formation and accumulation of 608 
MeV-N (upper panel) and IFN-β (lower panel) transcripts at 23 h.p.i. in 293T/CD46+ cells 609 
transiently expressing HEdF (grid columns) or HKAF (checked columns), respectively. 610 
293T/CD46+ cells were infected with MGV with different MOI, then they were transfected at 2 611 
h.p.i. (C) Dose response relationship of MeV-F transcription and IFN-β mRNA accumulation at 612 
30 h.p.i. and IFN-α/β secretion at 3 d.p.i. with the MOI of MeV used to infect 293T/CD46+ cells 613 
in the absence (dotted columns) or the presence of 10 µg/ml FIP (black columns). Data are mean 614 
values ± s.d. from two to three independent experiments. ND: not detected. † indicates cell 615 
cytoxicity. 616 
 617 
Figure 2. Similar dose-dependent inhibition of cell-cell fusion and IFN-β gene 618 
transcription by FIP. 293T/CD46+ (A and C) or HeLa (B) cells were infected with MeV MOI of 619 
1 prior to the addition of increasing amounts of FIP. (A) Micrographs of adherent cells stained 620 
with Hoechst 33342 (magnification x400) at 72 h.p.i. Cells containing more than three nuclei 621 
were considered as syncytia (white arrows). (B) Dose-dependent inhibition of cell-cell fusion by 622 
FIP quantified by colorimetric β-Gal reporter gene expression assay. (C) Dose-dependent 623 
inhibition of IFN-β mRNA accumulation by FIP at 30 h.p.i. Data are means ± s.d. of triplicates. 624 
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 625 
Figure 3. MeV-induced syncytia are dynamic entities with extended lifespan. MeV-626 
infected 293T/CD46+ were cultured overnight in the presence of FIP, then cultured in the absence 627 
(A, B) or the presence (C) of FIP (10 µg/ml) with recorded imaging for the next 60 h by time-628 
lapse microscopy. Images at a magnification x10 were extracted from Fig. S3Avideo.mov and 629 
another video not shown at 12.83 h, 15 h, 16.66 h, 25.33 h, 32.5 h and 35.33 h recorded times. 630 
(B) The duration of each stage was evaluated and expressed as mean ± s.d. of 17 microscopic 631 
areas from three to four separate experiments. The frequency was estimated and indicated as the 632 
proportion (%) that underwent transition through a given stage. 633 
 634 
Figure 4. Reciprocal trans-complementation of RIG-I and IFN-β deficient cells by 635 
MeV-induced fusion. RIG-I-deficient Huh7.5 or IFN-β-deficient Vero cells were infected with 636 
MeV at MOI of 1, and co-cultured 8 h later with uninfected Vero and Huh7.5 cells (ratio 1:1), 637 
respectively. The co-cultures were treated or not with 10 µg/ml of FIP. Cell-free supernatants 638 
were collected at 30 and 60 h.p.i. to measure IFN-α/β production. At the end of the co-culture, 639 
the cell monolayers were stained for fluorescent nuclei (magnification of x400) for counting 640 
within every syncytium indicated by arrows. Data are from one representative experiment out of 641 
two. ND: not detected. 642 
 643 
Figure 5. Unlike IFN-β gene, IRF-7 gene expression does not correlate with cell-cell 644 
fusion. 293T/CD46+ cells (left panels) and TEC (right panels) were either treated with 1000 645 
IU/ml of rhIFN-β or infected with MeV MOI of 1 and cultured in the absence or presence of FIP 646 
(10 µg/ml). Expression of IFN-β (upper dotted histograms) and IRF-7 (lower black histograms) 647 
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mRNA was quantified at 30 h.p.i. Data are from one representative experiment out of two or 648 
three. ND: not detected. 649 
 650 
Figure 6. Mature, but not immature, DC exhibit fusion-dependent amplification of IFN-651 
α and IFN-β responses. iDC and mDC were mock infected or infected with MeV strain at MOI 652 
of 0.1, in the absence (dotted columns) or the presence (black columns) of FIP (100 µg/ml). 653 
Syncytia formation was scored for each condition as described in Fig. S1. (A) CD150 expression 654 
on iDC and mDC cultures was analyzed by flow cytometry. (B) MeV-F transcript accumulation 655 
in iDC and mDC cultures was measured at 3 d.p.i. (C) Secreted bioactive IFN-α/β in cell-free 656 
supernatants collected at 3 d.p.i. IFN-α (D) and IFN-β (E) were measured by ELISA at 3 d.p.i. 657 
Accumulation of (F) IFN-β and (G) IRF-7 transcripts at 3 d.p.i. in cDC cultures in the absence or 658 
the presence of FIP (100 µg/ml). Data are mean values from two to five separate experiments. 659 
ND: not detected. 660 
 661 
Figure 7. Nuclear translocation of IRF-3 can be triggered within MeV-induced syncytia. 662 
(A) Nuclear translocation of GFP-IRF-3 within syncytia of 293T/CD46+ cells infected by MeV at 663 
MOI of 1. Microphotographs (magnification x400) showing morphology (upper panels), Hoescht 664 
labeled nuclei (middle panels) and GFP-IRF-3 labeled nuclei (bottom panels) at 30 h.p.i. 665 
Micrographs (magnification of x400) of uninfected cells (mock) and cells infected with MeV in 666 
the absence (MeV) or the presence of FIP (10 µg/ml, MeV+FIP) are shown. Data are from one 667 
representative experiment out of four. (B) Three-color overlays of confocal images showing the 668 
distribution of GFP-IRF-3 (green), N (red), nuclei (Draq5, blue) in 293T/CD46+ cells infected or 669 
not with MOI of 0.1 MeV in the presence or absence of FIP and transfected with GFP-IRF-3. 670 
Syncytium images were taken at three morphological stages, flat adherent, retracting and smooth 671 
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ball, respectively. The whole set of one-color images used to build the overlays is shown in the 672 
supplementary Fig.7SB. (C) Nuclear localization of endogenous IRF-3 in MGC derived from 673 
MeV-infected mDC. mDC were mock-treated (left panel, magnification x63) or infected with 674 
MeV at a MOI of 0.1 in the absence (middle panel, magnification x40) or the presence (right 675 
panel, magnification x63) of FIP (100 µg/ml). 3 d.p.i., mDC culture were stained with anti-IRF-3 676 
(green, left panel) and with nucleus staining (Hoechst 33343, blue). Cells were analyzed with an 677 
axioplan microscope. 678 
 679 
LEGENDS TO SUPPLEMENTAL DATA 680 
Figure S3Avideo.mov. Time-lapse microscopy of MeV-infected 293T/CD46+ in the 681 
absence of FIP. Animation Format: 380x331 million; sequence, FPS 3,75; Reading: IPS 9; Flow: 682 
9,46 mbits/sec; Duration: 9,26 sec; Size and actual size: 100%: 338x331 pixels (see material and 683 
methods and legends to Figure 3 for details). 684 
 685 
Figure S7Cvideo.mov. Nuclear endogenous IRF3 localisation within MeV-induced 686 
MGC from mDC. z stak compilation of images from MeV-infected mDC in the absence of FIP 687 
(see material and methods). 688 
 689 
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